Guirado, Ignacio (2019) Evaluación y optimización de irradiadores para fabricar molibdeno 99. / Device optimization for molybdenum 99 production. Proyecto Integrador Ingeniería Nuclear, Universidad Nacional de Cuyo, Instituto Balseiro.
![[img]](/style/images/fileicons/application_pdf.png)
| PDF (Tesis) Español 5Mb |
Resumen en español
En primera instancia, se presenta información que permite conocer las razones por las cuales es necesario llevar a cabo un estudio relacionado con la optimización de la producción de Molibdeno 99. Ademas, se expone información de algunos reactores nucleares productores, y de sus instalaciones para la producción de dicho radioisótopo. Luego, a partir de un enfoque neutrónico y termo hidráulico, se realiza un análisis de la producción de molibdeno al variar distintos parámetros físicos y geométricos del dispositivo de producción y del reactor. Finalmente, se obtienen distintas conclusiones acerca de las tendencias que permiten optimizar la producción de Mo 99.
Resumen en inglés
Firstly, information that permit know the main reasons why it is necesary carry out an estudy about Molybdenum 99 optimization is presented. Furthermore, information about some radioisotope production reactors is presented, as well as information related with their radioisotope production facilities. Then, by mean a neutronic and termo hidraulic focus, an analysis of molybdenum production is performed, when diverse physics and geometrics parameters of the production facility and the reactor are variated. Finally, different conclusions are obtained about the trends that allow optimize Mo 99 production.
| Tipo de objeto: | Tesis (Proyecto Integrador Ingeniería Nuclear) |
|---|---|
| Palabras Clave: | Molybdenum; Molibdeno; Potencia; Reactivity; Reactividad; Radioisotopes; Radioisótopos. |
| Referencias: | [1] Herbert, R., Kulke, W., Shepherd, R. The use of technetium 99m as a clinical tracer element. Postgraduate medical journal, 41 (481), 656, 1965. 2 [2] Arano, Y. Recent advances in tc-99m radio pharmaceuticals. Annals of nuclear medicine, 16, 79{93, 05 2002. 3 [3] COSTA, G. M. D. E. CONTROL DE CALIDAD DE GENERADORES DE MOLIBDENO-99/TECNECIO-99m SECA. Tesis Doctoral, UNIVERSIDAD COMPLUTENSE DE MADRID, 1993. 4, 6, 7 [4] News, W. N. Darlington to supply molybdenum-99. World Nuclear News, June 2018. 7 [5] IAEA. Non-heu production technologies for molybdenum-99 and technetium-99m. IAEA NUCLEAR ENERGY SERIES, 12 2013. 8, 9 [6] HEALTH, E. C., DIRECTORATE-GENERAL, C. Preliminary report on supply of radioisotopes for medical use and current developments in nuclear medicine, October 2009. 12 [7] Charlton, M. K. 2017 medical isotope supply review: 99mo/99mtc market demand and production capacity projection 2017-2022. The Supply of Medical Radioiso- topes, April 2017. 12 [8] Jaroszewicz, J., Marcinkowska, Z., Krzysztof, P. Production of ssion product 99mo using high-enriched uranium plates in polish nuclear research reactor maria: Technology and neutronic analysis. Nukleonika, 59, 01 2014. 93 [9] Krzysztoszek, G. Current and future utilisation of maria research reactor. Euro- pean research reactor conference, 05 2016. 93 [10] Krzysztoszek, G. Maria research reactor in supply chain of mo-99. Topical Meeting on Molybdenum-99 Technological Development, 09 2015. 93 [11] Ponsard, B. Irradiation of leu targets in the br2 reactor for mo-99 production. Topical Meeting on Molybdenum-99 Technological Development, 09 2015. 96 [12] Salacz, J. Production of ssion mo-99, i-131 and xe-133. Fission Molybdenum por medical use, 10 1989. 96 [13] Licht, J., Dionne, B. Loss-of- flow simulations for the conversion of br2 to low enriched uranium fuel. INTERNATIONAL MEETING ON REDUCED ENRICH- MENT FOR RESEARCH AND TEST REACTOR, 10 2014. 96 [14] Marchand, L. Irradiation of u-235 in the hfr petten for the production of mo-99, i-131 and xe-133 radioisotopes. Fission Molybdenum por medical use, 10 1989. 97 [15] de Haas, G.-J. The high flux reactor (hfr). Catalogue of research reactors, 06 2013. 97 [16] BALL, R. Characteristics of nuclear reactors used for the production of molybdenum-99. 97 [17] Marchand, L. Irradiation of u-235 in the osiris reactor for the production of mo-99, i-131 and xe-133 radioisotopes. Fission Molybdenum por medical use, 10 1989. 99 [18] Pinem, S., Susilo, J., Surbakti, T., Sembiring, T. Optimization of radioisotope production at rsg-gas reactor using deterministic method. Journal of Indonesian Technology, 35, 37, 01 2012. 99 [19] Cifuentes, G. Use of electrodeposition of nickel in the manufacture of leu annular targets. Journal of the Chilean Chemical Society, 58, 2102{2105, 12 2013. 99 [20] Sukmanto, D. Evaluation of operating performance of the reactor coolant system of rsg-gas using chemcad6.1.4. ICoNETS, 09 2016. 99 [21] Atta Mohammad, M. I., Tayyab Mahmood. Fission moly production at parr-1 using leu plate type target. Nuclear Engineering and Design, 11 2008. 101 [22] A. Mushtaq, I. H. B. T. M. T. M. Z. A. Q. Z., Massod Iqbal. Neutronic and thermal hydraulic analysis for production of ssion molybdenum-99 at pakistan research reactor-1. Annals of Nuclear Energy, 06 2007. 103 [23] K. Shaat, M., Gaheen, M. Utilization of egyptian research reactor and modes of collaboration, 06 2019. 106 [24] Egypt nal report for the crp on \developing techniques for small- scale, indigenous production of mo-99 using lowenriched uranium (leu) or neutron activation". 106 [25] Mohamed, F. M. Analysis of Reactivity Accidents in MTR for Various Protection System Parameters and Core Conditions. Proyecto Fin de Carrera, Alexandria University, 2O11. 106 [26] Bsebsu, A. F., F. M. Proyecto Fin de Carrera. 108 [27] Management of radioactive waste from mo-99 production". 113 |
| Materias: | Ingeniería nuclear > Neutrónica Ingeniería mecánica > Termohidráulica |
| Divisiones: | INVAP |
| Código ID: | 831 |
| Depositado Por: | Tamara Cárcamo |
| Depositado En: | 28 Oct 2019 11:54 |
| Última Modificación: | 28 Oct 2019 11:54 |
Personal del repositorio solamente: página de control del documento
